Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-22677922转801 |
| Mobile: | 18126518403 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Remimazolam Impurity 1 | C5H8O2 | 623-43-8 | Details |
| Remimazolam Impurity 8 | C3H6O | 75-56-9 | Details |
| Apixaban Impurity 54 | C8H11NO | 156-43-4 | Details |
| Empagliflozin Impurity 65 | C5H11NO | 109-02-4 | Details |
| Apixaban Impurity 53 | C6H6ClN | 106-47-8 | Details |
| Remimazolam Impurity 6 | C6H15NO2 | 110-97-4 | Details |
| Pitavastatin Impurity 7 | C32H36FNO4 | 147489-06-3 | Details |
| Pitavastatin Impurity 5 | Details |
| Pramipexole Impurity V | Details |
| Empagliflozin Impurity 66 | C3H9ClSi | 75-77-4 | Details |
| Remdesivir impurity | C12H16N5O13P3 | 1355149-45-9 | Details |
| Pitavastatin Impurity 23 | Details |
| Pitavastatin Impurity 13 | Details |
| Pramipexole Impurity Z | Details |
| Parecoxib Impurity 9 | C32H25N3O6S2 | 1373038-60-8 | Details |
| Pitavastatin Impurity 23 | C28H28FNO4 | 1467166-39-7 | Details |
| Parecoxib Impurity 25 | C19H19N2NaO4S | 198470-85-8 | Details |
| Parecoxib Impurity 26 | C16H13NO | 75115-00-3 | Details |
| Pitavastatin Impurity 11 | Details |
| Pitavastatin Impurity 20 | Details |
| sofosbuvir impurity 3 | C31H26ClN3O7 | 1496551-70-2 | Details |
| Parecoxib sodium Impurity 31 | C19H18N2O4S | 477594-28-8 | Details |
| Parecoxib sodium Impurity 31 | C20H20N2O4S | 198470-91-6 | Details |
| Tofacitinib Impurity 2 | C20H25N5 | 477600-73-0 | Details |
| Parecoxib Impurity 20 | C16H14N2O3S | 181696-12-8 | Details |
| Pitavastatin Impurity 22 | Details |
| Sofosbuvir Impurity A | C22H29FN3O9P | 1496552-16-9 | Details |
| Parecoxib sodium Impurity 31 | C16H14N2O4S | 501093-49-8 | Details |
| Favipiravir Impurity | Details |
| Tofacitinib Impurity 3 | C13H19N5 | 1206825-36-6 | Details |
| Pitavastatin Impurity 8 | C26H26FNO4 | 849811-78-5 | Details |
| Parecoxib Impurity 2 | C16H12ClNO3S | 509074-26-4 | Details |
| Parecoxib Impurity 10 | C18H16N2O4S | 198471-06-6 | Details |
| Parecoxib Impurity 23 | C20H20N2O4S | 198470-82-5 | Details |
| Apixaban Impurity 71 | C6H10Cl2O | 99585-01-0 | Details |
| Tofacitinib Impurity E | C13H18ClN5 | 1616760-97-4 | Details |
| Parecoxib Impurity 21 | C16H15NO2 | 181696-73-1 | Details |
| Pitavastatin Impurity 18 | C25H26CaFNO4 | 254452-88-5 | Details |
| Tofacitinib Impurity 5 | C14H23ClN2 | 1062580-52-2 | Details |
| Clavulanic acid Impurity A | C8H12N2O2 | 4744-51-8 | Details |
| Pitavastatin Impurity 16 | C25H22FNO4 | 1187966-93-3 | Details |
| Potassium clavulanate | C8H10KNO5 | 61177-45-5 | Details |
| Tofacitinib Impurity 1 | C13H10ClN3O2S | 479633-63-1 | Details |
| Clavulanic acid Impurity B | C11H16N2O4 | 96681-85-5 | Details |
| Ambroxol Impurity 7 | C13H20BrClN2O | 101900-44-1 | Details |
| Tofacitinib Impurity C | C16H20N6O | 1092578-47-6 | Details |
| Pitavastatin Impurity 21 | C25H26CaFNO4 | 254452-92-1 | Details |
| Parecoxib Impurity 11 | C19H18N2O4S | 1709956-89-7 | Details |
| Parecoxib Impurity 4 | C16H14N2O3S | 181695-72-7 | Details |
| Tofacitinib Impurity 4 | C27H31N5O2S | 923036-30-0 | Details |
| Parecoxib sodium Impurity 31 | C32H24N2O4S | 2338845-31-9 | Details |
| Pitavastatin Impurity 17 | C29H32FNO4 | 586966-54-3 | Details |
| Pitavastatin Impurity 19 | C25H24FNO4 | 769908-13-6 | Details |
| Parecoxib Impurity T | C19H18N2O5S | 198471-83-9 | Details |
| Parecoxib Impurity 24 | C20H21N2NaO4S | 198470-83-6 | Details |
| Parecoxib Impurity 15 | C18H18N2O3S | 473465-11-1 | Details |
| Tofacitinib Impurity 7 | C6H3Cl2N3 | 90213-66-4 | Details |
| Apixaban Impurity 11 | C22H22N4O4 | 503615-07-4 | Details |
| Apixaban Impurity S2 | C20H26ClN3O3 | 1643330-62-4 | Details |
| Tofacitinib Impurity 6 | C6H4ClN3 | 3680-69-1 | Details |
| Ambroxol Impurity 6 | C14H16Br2N2O | 2088879-81-4 | Details |
| Parecoxib Impurity 12 | C19H18N2O4S | 2229657-81-0 | Details |
| Apixaban Impurity BMS-778960-01 | C26H27N5O4 | 2098457-92-0 | Details |
| Empagliflozin Impurity 69 | C6H12O6 | 7660-25-5 | Details |
| Remimazolam Impurity 2 | C5H7BrO2 | 1117-71-1 | Details |
| Ethyl (E)-7-[4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate | C27H26FNO4 | 148901-69-3 | Details |
| Ambroxol EP Impurity B | C14H18Br2N2O | 18683-95-9 | Details |
| Parecoxib Impurity 6 | C16H14N2O3S | 1373038-56-2 | Details |
| Remimazolam Impurity 4 | C4H5BrO2 | 13991-36-1 | Details |
| Empagliflozin Impurity 68 | C6H12O6 | 50-99-7 | Details |
| Empagliflozin Impurity 70 | C6H12O7 | 526-95-4 | Details |
| Olopatadine Impurity 5 | C21H23NO4 | 173174-07-7 | Details |
| Parecoxib Impurity 27 | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
| Apixaban Impurity 15 | C21H27N3O3 | 1686149-78-9 | Details |
| Remimazolam Impurity 5 | C7H6BrNO2 | 20776-51-6 | Details |
| Apixaban Impurity C | C27H28N4O5 | 503614-91-3 | Details |
| Tofacitinib Impurity FD+DX | C16H20N6O | 1092578-48-7 | Details |
| Pitavastatin Impurity 12 | C25H26CaFNO4 | 1159588-21-2 | Details |
| Pitavastatin Impurity 9 | C27H28FNO4 | 167073-19-0 | Details |
| Apixaban Impurity 36 | C24H23N5O3 | 1801881-17-3 | Details |
| Pitavastatin Impurity 2 | Details |
| Apixaban Impurity 30 | C25H25N5O4 | 503612-47-3 | Details |
| Parecoxib Impurity 1 | C16H13NO | 37928-17-9 | Details |
| Ambroxol Impurity 10 | C7H5Br2NO2 | 609-85-8 | Details |
| Apixaban Impurity 49 | C15H17N3O4 | 503615-03-0 | Details |
| Tofacitinib Impurity A | C16H20N6O | 1092578-46-5 | Details |
| Empagliflozin Impurity 76 | C11H14O4S | 219823-47-9 | Details |
| Epalrestat | C15H13NO3S2 | 82159-09-9 | Details |
| Pitavastatin Impurity 1 | Details |
| Pitavastatin Impurity 38 | C32H36FNO4 | 154170-27-1 | Details |
| Ambroxol Impurity 11 | C13H16Br2N2O2 | 105735-86-2 | Details |
| Ambroxol EP Impurity D | C13H19Br2ClN2O | 1384955-66-1 | Details |
| Empagliflozin Impurity 64 | C3H10OSi | 1066-40-6 | Details |
| Benazepril Enantiomer HCl | C24H28N2O5 | 131064-75-0 | Details |
| Tofacitinib Impurity D | C20H25N5 | 1252883-90-1 | Details |
| Apixaban Impurity BMS-724914-01 | C25H28N6O4 | 2187409-01-2 | Details |
| Pitavastatin Impurity 4 | C25H24FNO5 | 1980814-87-6 | Details |
| Remimazolam Impurity 7 | C9H21NO3 | 122-20-3 | Details |
| Apixaban Impurity 41 | C25H24N4O5 | 503614-92-4 | Details |
| Ambroxol EP Impurity C | C13H16Br2N2O | 50910-53-7 | Details |
| Parecoxib Impurity 13 | C22H23N3O7S2 | 1708094-99-8 | Details |
| Apixaban Impurity 12 | C20H19N5O3 | 1423803-24-0 | Details |
| Ambroxol hydrochloride | C13H18Br2N2O | 18683-91-5 | Details |
| Apixaban Impurity 13 | C11H13ClN2O3 | 27143-07-3 | Details |
| Parecoxib Impurity 5 | C16H14N2O3S | 386273-25-2 | Details |
| Pitavastatin Impurity 10 | C25H22FNO3 | 141750-63-2 | Details |
| Empagliflozin Impurity 67 | C7H10N2 | 1122-58-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 | ||||